Shares of Arkema SA (OTCMKTS:ARKAY - Get Free Report) have earned an average recommendation of "Hold" from the eight brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation and one has assigned a buy recommendation to the company.
ARKAY has been the topic of several recent research reports. Sanford C. Bernstein upgraded Arkema from a "strong sell" rating to a "hold" rating in a report on Monday, April 20th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Arkema in a report on Tuesday, June 23rd. Zacks Research raised shares of Arkema from a "strong sell" rating to a "hold" rating in a research note on Monday, May 4th. Barclays upgraded shares of Arkema from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 12th. Finally, Kepler Capital Markets downgraded shares of Arkema from a "hold" rating to a "strong sell" rating in a research note on Thursday, May 7th.
Check Out Our Latest Analysis on Arkema
Arkema Price Performance
OTCMKTS:ARKAY opened at $72.00 on Monday. The stock's fifty day moving average price is $66.06 and its two-hundred day moving average price is $68.00. Arkema has a 52-week low of $56.28 and a 52-week high of $79.36. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.64 and a current ratio of 2.25. The company has a market cap of $5.48 billion, a price-to-earnings ratio of 248.28 and a beta of 0.85.
Arkema (OTCMKTS:ARKAY - Get Free Report) last released its earnings results on Thursday, July 30th. The basic materials company reported $1.98 EPS for the quarter, beating the consensus estimate of $1.86 by $0.12. The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.86 billion. Arkema had a return on equity of 4.27% and a net margin of 0.67%. On average, analysts anticipate that Arkema will post 3.68 EPS for the current year.
Arkema Company Profile
(
Get Free Report)
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
